News
ONCSQ
0.0001
NaN%
--
Weekly Report: what happened at ONCSQ last week (0708-0712)?
Weekly Report · 4d ago
Weekly Report: what happened at ONCSQ last week (0701-0705)?
Weekly Report · 07/08 11:40
Weekly Report: what happened at ONCSQ last week (0624-0628)?
Weekly Report · 07/01 11:41
Weekly Report: what happened at ONCSQ last week (0617-0621)?
Weekly Report · 06/24 11:50
Weekly Report: what happened at ONCSQ last week (0610-0614)?
Weekly Report · 06/17 11:39
Weekly Report: what happened at ONCSQ last week (0603-0607)?
Weekly Report · 06/10 11:42
Weekly Report: what happened at ONCSQ last week (0527-0531)?
Weekly Report · 06/03 11:45
Weekly Report: what happened at ONCSQ last week (0520-0524)?
Weekly Report · 05/27 11:51
Weekly Report: what happened at ONCSQ last week (0513-0517)?
Weekly Report · 05/20 11:42
Weekly Report: what happened at ONCSQ last week (0506-0510)?
Weekly Report · 05/13 11:57
Weekly Report: what happened at ONCSQ last week (0429-0503)?
Weekly Report · 05/06 12:07
Weekly Report: what happened at ONCSQ last week (0422-0426)?
Weekly Report · 04/29 12:15
Weekly Report: what happened at ONCSQ last week (0415-0419)?
Weekly Report · 04/22 11:59
Weekly Report: what happened at ONCSQ last week (0408-0412)?
Weekly Report · 04/15 11:49
Weekly Report: what happened at ONCSQ last week (0401-0405)?
Weekly Report · 04/08 11:55
Weekly Report: what happened at ONCSQ last week (0325-0329)?
Weekly Report · 04/01 11:52
Weekly Report: what happened at ONCSQ last week (0318-0322)?
Weekly Report · 03/25 11:56
Weekly Report: what happened at ONCSQ last week (0311-0315)?
Weekly Report · 03/18 11:53
Biotech bankruptcies hit a record despite sector’s recovery
Healthcare Biotech bankruptcies hit a record despite sector’s recovery. More biotech firms filed for Chapter 11 bankruptcy than any other year since 2010. In 2023, 18 biotech companies petitioned for court-mediated protection, compared to eight in 2022. The record number of biotech bankruptcies contrasts with the industry's recent gains.
Seeking Alpha · 03/14 18:54
Weekly Report: what happened at ONCSQ last week (0304-0308)?
Weekly Report · 03/11 11:49
More
Webull provides a variety of real-time ONCSQ stock news. You can receive the latest news about Oncosec Med Inc through multiple platforms. This information may help you make smarter investment decisions.
About ONCSQ
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method that enables transient expression of recombinant therapeutic molecules in cells. The OMS EP Device is designed to promote cellular uptake of plasmid DNA injected directly into solid tumors to allow subsequent expression of the encoded therapeutic protein. The OMS EP Device can be adapted to treat different tumor types and consists of an electrical pulse generator and a disposable applicator. Its lead product candidate, tavokinogene telseplasmid (TAVO), is a plasmid encoding human interleukin-12.